AMWL - Earnings announcements

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the first quarter ended March 31, 2026. The company's first quarter earnings report can be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/b826q95x/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled

BOSTON, April 20, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report first quarter 2026 operating results after stock market trading hours on Tuesday, May 5. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company's fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/7o2zjx2o/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a si

BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter and full year 2025 operating results after stock market trading hours on Thursday, Feb. 12. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at

BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third quarter ended September 30. The company's third quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled

BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report third quarter 2025 operating results after stock market trading hours on Tuesday, Nov. 4. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company's second quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. W

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on Tuesday, Aug. 5. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days. About Amwell  Amwell offers payers and

BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/zsp4abpw. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. Abo

BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days. About Amwell  Am

BOSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the third quarter ended Sept. 30, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the third quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Oct. 30. The call can be accessed via a live audio webcast at investors.amwell.com or by dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for international participants, referencing conference ID number 7830032. A replay of the call will

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days. About Amwell  Amwell is a leading hybrid care, delivery enablement platfor

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the second quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio webcast at investors.amwell.com or by dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for international participants, referencing conference ID number 7830032. A replay o

Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website. Alternatively, participants can call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The call ID number is 7830032. A webcast replay of th

Boston, May 01, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the first quarter ended March 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, May 1. The call can be accessed via a live audio webcast at investors.amwell.com or by dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for international participants, referencing conference ID #7830032. A replay of the call

Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website. Alternatively, participants can call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The call ID number is 7830032. A webcast replay of the cal

Boston, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leader in hybrid care enablement, today announced financial results for the fourth quarter and full year ended Dec. 31, 2023. Amwell is a small-cap growth company and a leading provider of healthcare software as a service.  Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2023 earnings report.   Amwell will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, Feb.14. The call can be accessed via a live audio webcast at investors.amwell.com or by dialing 1-888-510-2008 for U.S. participants, or 1-646-960-0306 for international partic

Boston, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital healthcare enablement, will report its fourth quarter 2023 operating results on Wednesday, Feb. 14.  Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.  The audio webcast can be accessed by visiting the Investors section of the company's website. Alternatively, participants can call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The call ID number is 7830032.   A webcast re

Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announced financial results for the third quarter ended Sept. 30, 2023. Amwell Third Quarter 2023 Highlights: Recorded Total Revenue of $61.9 million Achieved subscription revenue of $28.4 million Recorded Amwell Medical Group ("AMG") visit revenue of $26.7 million Reported gross margin of 35% Net loss was ($137.1) million, compared to ($93.5) million in second quarter of 2023. Net loss reflects non-cash goodwill impairment charges of $78.9 million recorded in the third quarter of 2023 and $27.3 million recorded in the second quarter of 2023 Adjusted EBITDA improved to ($38.5) million compared to ($45.3) mi

Amwell® (NYSE:AMWL), a leader in hybrid health care enablement, today announced it will report its third-quarter 2023 operating results on Wednesday, November 1, 2023. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. Eastern time to review the company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The conference ID number for the live call w

Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announced financial results for the second quarter ended June 30, 2023. Amwell Second Quarter 2023 Highlights: Recorded Total Revenue of $62.4 million Achieved subscription revenue of $28.0 million Recorded AMG Visit revenue of $28.1 million Reported gross margin of 39% Net loss was ($93.5) million, compared to ($398.5) million in first quarter of 2023. Net loss reflects non-cash goodwill impairment charges of $27.3 million recorded in the second quarter of 2023 and $330.3 million recorded in the first quarter of 2023 Adjusted EBITDA was ($45.3) million compared to ($44.6) million in the first quarter of 20

Amwell® (NYSE:AMWL), a leader in hybrid health care enablement, today announced it will report its second quarter 2023 operating results on Wed., Aug. 2, 2023. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. Eastern Time to review the company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The conference ID number for the live call will be 7

Amwell® (NYSE:AMWL), a leader in digital healthcare enablement, today announced financial results for the first quarter ended March 31, 2023. Amwell First Quarter 2023 Highlights: Recorded Total Revenue of $64.0 million Achieved subscription revenue of $28.7 million Recorded AMG Visit revenue of $32.5 million Reported gross margin of 39.5% Net loss was ($398.5) million, compared to ($61.6) million in fourth quarter of 2022 which reflects a non-cash goodwill impairment charge of $330.3 million recorded in the first quarter of 2023 Adjusted EBITDA was ($44.6) million compared to ($43.4) million in fourth quarter of 2022 Total active providers rose 8% to 108,000 co

Amwell® (NYSE:AMWL), a leader in digital health care enablement, today announced it will report its first-quarter 2023 operating results on Wed., May 3, 2023. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. Eastern time to review the company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The conference ID number for the live call will be 78

Amwell®, (NYSE:AMWL) a leader in digital healthcare enablement, today announced that it will report fourth quarter, ended December 31, 2022, operating results on Wednesday, February 22, 2023. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The conference ID

Amwell®, (NYSE:AMWL) a leader in digital healthcare enablement, today announced that it will report third quarter ended September 30, 2022 operating results on Monday November 7, 2022. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the web

Amwell®, (NYSE:AMWL) a digital care delivery leader, today announced that it will report second quarter ended June 30, 2022 operating results on Thursday August 4, 2022. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternati

Amwell®, (NYSE:AMWL) a national telehealth leader, today announced that it will report first quarter ended March 31, 2022 operating results on Monday, May 9, 2022. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively,

Amwell®, (NYSE:AMWL) (the "Company") a national telehealth leader, today announced that it will report fourth quarter and full year ended December 31, 2021 operating results on Thursday, February 24, 2022. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be nee

Amwell®, (NYSE:AMWL) (the "Company") a national telehealth leader, today announced that it will report third quarter ended September 30, 2021, operating results on Wednesday, November 10, 2021. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to acces

Amwell®, (NYSE:AMWL) (the "Company") a national telehealth leader, today announced that it will report second quarter ended June 30, 2021 operating results on Wednesday, August 11, 2021. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by visiting the Investors section of the Company's website at investors.amwell.com. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the w